LEGEND BIOTECH CORPORATION earnings per share and revenue

9LB earnings per share for the last quarter are -0.31 EUR whereas the estimation was -0.30 EUR which accounts for -3.11% surprise. Company revenue for the same period amounts to 143.89 M EUR despite the estimated figure of 129.25 M EUR. Estimated earnings per share for the next quarter are -0.24 EUR, and revenue is expected to reach 169.40 M EUR. Also watch annual changes over time to get a bigger picture of 9LB earnings per share and revenue dynamics.